Results 291 to 300 of about 1,043,535 (340)

GnRH agonist improves CLBR after one IVF cycle: a propensity score-matched and molecular mechanism study. [PDF]

Reprod Fertil
Cai X, Ding H, Liu Y, Xiong W.
europepmc   +1 more source

Utility of GnRH Agonists before embryo transfer in women with adenomyosis: Systematic review and meta-analysis. [PDF]

JBRA Assist Reprod
González-Comadran M, Olmos EA, Mariño MAA, Vizcaíno MAC.   +3 more
europepmc   +1 more source

Role of TLR4 in Enteric Glia Response to Clostridioides Difficile Toxins: Insights From In Vivo and In Vitro Studies. [PDF]

J Cell Mol Med
Barbosa MLL, Costa DVDS, de Pacífico DM, Rebouças CDSM, Warren CA, de Leitão RFC, Brito GAC.   +6 more
europepmc   +1 more source

Olanzapine for nausea and vomiting in people with breast cancer treated with trastuzumab deruxtecan: plain language summary of the ERICA study. [PDF]

Future Oncol
Sakai H, Tsurutani J, Ozaki Y, Ishiguro H, Nozawa K, Yamanaka T, Aogi K, Matsumoto K, Iwasa T, Tokiwa M, Tsuneizumi M, Miyoshi Y, Kitagawa C, Yamamoto M, Takano Y, Imamura CK, Chiba Y, Takiguchi D, Ezumi T, Takano T.   +19 more
europepmc   +1 more source

Molecular Insights into Bromocriptine Binding to GPCRs Within Histamine-Linked Signaling Networks: Network Pharmacology, Pharmacophore Modeling, and Molecular Dynamics Simulation. [PDF]

Int J Mol Sci
Dermawan D, Elbouamri L, Chtita S, Alotaiq N.   +3 more
europepmc   +1 more source

Structural insights into selective and dual antagonism of EP2 and EP4 prostaglandin receptors. [PDF]

EMBO J
Wu Y, Zhang H, Xu J, Wu K, Hu W, He X, Wang G, Wu C, Xu HE.   +8 more
europepmc   +1 more source

The free fatty acid 2 receptor regulates the activation potency of C5a and the sensitivity to the antagonist avacopan

Khan Z, Levin NK, Dahlgren C, Sundqvist M, Khan F, Forsman H, Björkman L.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vasopressin Antagonists

New England Journal of Medicine, 2015
SCOPUS: le.j ; info:eu-repo/semantics ...
Vandergheynst, Frederic, Gankam Kengne, Fabrice, Decaux, Guy   +2 more
openaire   +4 more sources

Endothelin antagonists

The Lancet, 1999
The very potent endogenous vasoconstrictor endothelin was discovered in 1988. We know now that there are three isoforms (1, 2, and 3) and two receptor subtypes (A and B). A whole range of peptide and non-peptide antagonists has been developed, some selective for A or B receptors and others with non-selective A/B antagonistic activity.
A, Benigni, G, Remuzzi
openaire   +2 more sources